[Low-dosage ASA should not be given as primary prevention. The risk is greater than the benefit--also in high risk of cardiovascular disease].
Autor: | Håkansson J; Krokoms hälsocentral. jan.hakansson@jll.se, Hernborg A |
---|---|
Jazyk: | švédština |
Zdroj: | Lakartidningen [Lakartidningen] 2010 Feb 3-9; Vol. 107 (5), pp. 260-2. |
Databáze: | MEDLINE |
Externí odkaz: |